ABVC BioPharma, Inc. (ABVC)

0.9325 -0.09 (-8.58%) USD  |  NASDAQ  |  Oct 15, 16:00
0.94 +0.01 (+0.80%) After-Hours: 20:00
More

ABVC BioPharma Cash from Operations (TTM) : -2.691M for June 30, 2026

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 -2.691M
March 31, 2026 -3.341M
December 31, 2025 -2.986M
September 30, 2025 -2.646M
June 30, 2025 -1.621M
March 31, 2025 -0.9385M
December 31, 2024 -1.354M
September 30, 2024 -1.693M
June 30, 2024 -2.614M
March 31, 2024 -3.270M
December 31, 2023 -4.187M
September 30, 2023 -4.243M
June 30, 2023 -3.874M
March 31, 2023 -6.460M
December 31, 2022 -7.638M
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021
September 30, 2021 -9.946M
June 30, 2021 -6.760M
March 31, 2021 -6.757M
December 31, 2020 -6.042M
September 30, 2020 -3.50M
June 30, 2020 -4.271M
Date Value
March 31, 2020 -3.396M
December 31, 2019 -3.308M
September 30, 2019 -2.711M
June 30, 2019 -2.483M
March 31, 2019 -2.267M
December 31, 2018 -2.255M
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017
June 30, 2017
December 31, 2016 -2.825M
September 30, 2016 -3.475M
June 30, 2016 -3.266M
March 31, 2016 -0.4296M
December 31, 2015 -0.875M
September 30, 2015 -0.0007M
June 30, 2015 -0.0032M
March 31, 2015 -0.0056M
December 31, 2014 -0.0056M
September 30, 2014 -0.0056M
June 30, 2014 -0.0001M
March 31, 2014 -0.0002M
December 31, 2013 -0.0014M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Anika Therapeutics, Inc. 5.977M
Perspective Therapeutics, Inc. -93.07M
MiMedx Group, Inc. 46.13M
Abbott Laboratories 9.905B
AngioDynamics, Inc. 3.673M